- Home
- LAC vs QURE Comparison
LAC vs QURE Comparison
Compare LAC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAC
- QURE
- Stock Information
- Founded
- LAC 2023
- QURE 1998
- Country
- LAC Canada
- QURE Netherlands
- Employees
- LAC N/A
- QURE N/A
- Industry
- LAC Metal Mining
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- LAC Basic Materials
- QURE Health Care
- Exchange
- LAC Nasdaq
- QURE Nasdaq
- Market Cap
- LAC 604.2M
- QURE 725.4M
- IPO Year
- LAC N/A
- QURE 2007
- Fundamental
- Price
- LAC $2.65
- QURE $15.16
- Analyst Decision
- LAC Hold
- QURE Strong Buy
- Analyst Count
- LAC 6
- QURE 10
- Target Price
- LAC $4.29
- QURE $37.20
- AVG Volume (30 Days)
- LAC 4.6M
- QURE 2.0M
- Earning Date
- LAC 05-15-2025
- QURE 05-09-2025
- Dividend Yield
- LAC N/A
- QURE N/A
- EPS Growth
- LAC N/A
- QURE N/A
- EPS
- LAC N/A
- QURE N/A
- Revenue
- LAC N/A
- QURE $20,201,000.00
- Revenue This Year
- LAC N/A
- QURE $60.54
- Revenue Next Year
- LAC N/A
- QURE $183.28
- P/E Ratio
- LAC N/A
- QURE N/A
- Revenue Growth
- LAC N/A
- QURE 6.30
- 52 Week Low
- LAC $2.02
- QURE $3.73
- 52 Week High
- LAC $5.20
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- LAC 38.41
- QURE 57.88
- Support Level
- LAC $2.66
- QURE $14.06
- Resistance Level
- LAC $2.81
- QURE $15.50
- Average True Range (ATR)
- LAC 0.13
- QURE 1.03
- MACD
- LAC -0.04
- QURE -0.01
- Stochastic Oscillator
- LAC 9.17
- QURE 72.12
About LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.